Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination

Walid Shalata, Daniel Levin, Janna Fridman, Victoria Makarov, Muhammed Iraqi, Mitchell Golosky, Keren Rouvinov, Waleed Kian, Alexander Yakobson

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

In the following report, we describe 11 patients with various diagnoses and different treatment statuses (newly diagnosed, receiving treatment, or follow‐up) of oncological diseases (breast, lymphoma, melanoma, and head and neck cancers). The patients underwent PET‐CT for disease staging or follow‐up and it was noted that all patients had areas of hypermetabolic uptake in the axillary lymph‐nodes of the ipsilateral upper extremity where the Pfizer‐BioNTech coronavirus (COVID‐19) vaccine was administered. Following further investigations, including an ultrasound (US), biopsies and an examination of medical records, it was concluded that these findings were the result of the vaccination and not a progression of pre‐existing disease.

Original languageEnglish
Pages (from-to)989-1000
Number of pages12
JournalCurrent Oncology
Volume29
Issue number2
DOIs
StatePublished - 1 Feb 2022

Keywords

  • COVID‐19
  • Coronavirus
  • Hypermetabolic uptake
  • Oncology
  • PET‐CT
  • Vaccine

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Metabolic Activity Assessment by 18F‐Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID‐19 Vaccination'. Together they form a unique fingerprint.

Cite this